drugset / Trial / NCT00601484
An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether PF-04383119 is effective in the treatment of pain associated with interstitial cystitis.
Timeline
- Start
- 2008-03-17
- Primary completion
- 2009-04-15
- Completion
- 2009-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tanezumab | Monoclonal antibody | 200 ug/kg | Intravenous |